Get the Stockscreener App
6.64
2.15%
0.14
Pre-market:
6.64
P 3 Health Partners Inc stock is traded at $6.64, with a volume of 16,823.
It is up +2.15% in the last 24 hours and up +5.56% over the past month.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
See More
Previous Close:
$6.50
Open:
$6.47
24h Volume:
16,823
Relative Volume:
1.95
Market Cap:
$21.70M
Revenue:
$1.18B
Net Income/Loss:
$-126.34M
P/E Ratio:
-0.00294
EPS:
-2260.66
Net Cash Flow:
$-94.09M
1W Performance:
+6.58%
1M Performance:
+5.56%
6M Performance:
-35.53%
1Y Performance:
-77.30%
1-Day Range:
$6.47
$6.93
1-Week Range:
$6.17
$6.93
52-Week Range:
$6.00
$32.54
P 3 Health Partners Inc Stock (PIII) Company Profile
Name
P 3 Health Partners Inc
Sector
Industry
Phone
312-822-8897
Address
2045 W GRAND AVE STE B, CHICAGO
Compare PIII with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PIII
P 3 Health Partners Inc
|
6.64 | 20.36M | 1.18B | -126.34M | -94.09M | -2,260.66 |
|
HCA
Hca Healthcare Inc
|
362.60 | 91.01B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
175.14 | 16.13B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.99 | 16.11B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
110.36 | 11.84B | 5.51B | 494.70M | 386.40M | 4.84 |
|
DVA
Davita Inc
|
143.38 | 10.84B | 12.82B | 936.34M | 1.47B | 10.74 |
P 3 Health Partners Inc Stock (PIII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-24 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-01-23 | Initiated | BTIG Research | Buy |
| Jun-30-23 | Initiated | TD Cowen | Market Perform |
P 3 Health Partners Inc Stock (PIII) Latest News
Is P3 Health Partners Inc. Equity Warrant a good long term investmentExplosive portfolio gains - Jammu Links News
P3 Health Partners (NASDAQ:PIII) Shares Up 2.2% – Should You Buy? - Defense World
P3 Health Partners Inc. Equity Warrant Stock Analysis and ForecastTremendous growth opportunities - Jammu Links News
What analysts say about P3 Health Partners Inc. stockFree Consultation - Jammu Links News
What makes P3 Health Partners Inc. Equity Warrant stock price move sharplyDaily Breakout Picks - Newser
Why P3 Health Partners Inc. Equity Warrant stock attracts strong analyst attentionHigh Probability Setups - Newser
Why P3 Health Partners Inc. stock attracts strong analyst attentionHigh Reward Swing Trades - Newser
How P3 Health Partners Inc. stock performs during market volatilityConsistent High Return Strategy - Newser
What makes P3 Health Partners Inc. stock price move sharplyFree Stock Market Group - Newser
How P3 Health Partners Inc. Equity Warrant stock performs during market volatilityFast Growing Stocks - Newser
$13.9B contract awarded for THP – The Peter Gilgan Mississauga Hospital - ReNew Canada
EllisDon-PCL joint venture to build new Mississauga hospital - On-Site Magazine
P3 Health Partners Inc. Announces Directorate Changes, Effective July 2, 2025 - MarketScreener
P3 Health Partners Appoints New Board Director - TipRanks
P3 Health Partners appoints CEO Aric Coffman to board following director resignation - Investing.com
P3 Health Partners (NASDAQ:PIII) Stock Price Up 0.7% – Should You Buy? - Defense World
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc. - GlobeNewswire
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now - sharewise
P3 Health Partners’ Shareholders Approve Key Proposals - TipRanks
PIIIP3 Health Partners Announces Third Quarter 2024 Results - mx.advfn.com
P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction - mx.advfn.com
UnitedHealth woes incite worry about its value-based partners - Modern Healthcare
P3 Health Partners (NASDAQ:PIII) Stock Price Down 3.4% – Should You Sell? - Defense World
p3 health partners enters financing agreement with vbc growth spv 5 - Investing.com
P3 Health Partners Secures $70M Financing Deal - TipRanks
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc. - GlobeNewswire Inc.
P3 Health Partners price target lowered to $8 from $12.50 at TD Cowen - Yahoo Finance
P3 Health Partners (PIII) Price Target Cut by TD Cowen | PIII Stock News - GuruFocus
Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII) - Yahoo Finance
Ardent Health Partners, Inc. Updates Name to Ardent Health, Inc. - Business Wire
Form 8.3Primary Health Properties plc - Business Wire
P3 Health Partners reaffirms $130M EBITDA improvement plan as operational initiatives accelerate in 2025 - MSN
P3 Health Partners Inc. (NASDAQ:PIII) Q1 2025 Earnings Call Transcript - Insider Monkey
P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
P3 Health Partners’ Earnings Call: Strategic Gains Amid Challenges - TipRanks
Earnings call transcript: P3 Health Partners Q1 2025 revenue falls short - Investing.com
P3 Health Partners Reports Q1 2025 Financial Results - TipRanks
Transcript : P3 Health Partners Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
P 3 Health Partners Inc Stock (PIII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):